Ascension Technology Corporation has been acquired by Roper Industries, Inc.
The private shareholders of Ascension Technology Corporation have sold all assets of the company to Roper Industries, Inc. for US$19 million.
Ascension Technology Corporation manufactures 3D magnetic tracking systems for image-guided navigation for minimal invasive surgery or diagnostic and therapeutic purposes. This allows for non-radiating navigation to the internal targets, such as tumors.
Roper Industries, Inc. designs, manufactures and distributes radio frequency products and services, industrial technology products, energy systems and controls, and medical and scientific imaging products and software.
Oaklins' team in Dallas initiated this transaction, advised the seller and assisted in its closing. Oaklins' team in Japan was also involved in this transaction.
Talk to the deal team
Bryan Livingston
Oaklins Capital Alliance
Related deals
MEDIK Hospital Design Group has been acquired by STERIS
The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.
Learn moreNiscon Inc. has been acquired by SGPS ShowRig
Niscon Inc. has been successfully acquired by SGPS ShowRig, a global provider of staging, rigging and automation for live entertainment. The acquisition reinforces SGPS Showrig’s commitment to pushing the boundaries of innovation in the entertainment industry. By adding Niscon’s unique motion-control technology to its portfolio, SGPS Showrig strengthens its ability to deliver cutting-edge, precision-driven solutions.
Learn morebioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG
Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.
Learn more